These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 9331782)
21. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146 [TBL] [Abstract][Full Text] [Related]
23. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Blanchard-Rohner G; Pollard AJ Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987 [TBL] [Abstract][Full Text] [Related]
24. Disease transmission: routes, contributing factors and herd immunity. O'Brien K Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363 [No Abstract] [Full Text] [Related]
25. [Immunogenicity of Haemophilus Influenzae]. Käyhty H Duodecim; 1996; 112(9):813-9. PubMed ID: 10592969 [No Abstract] [Full Text] [Related]
26. Current status and prospects for some improved and new bacterial vaccines. Robbins FC; Robbins JB Annu Rev Public Health; 1986; 7():105-25. PubMed ID: 3521639 [No Abstract] [Full Text] [Related]
27. Prevention of infections in hyposplenic and asplenic patients: an update. Melles DC; de Marie S Neth J Med; 2004 Feb; 62(2):45-52. PubMed ID: 15127830 [TBL] [Abstract][Full Text] [Related]
28. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Gessner BD; Adegbola RA Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility to invasive bacterial infections in children with sickle cell disease. Battersby AJ; Knox-Macaulay HH; Carrol ED Pediatr Blood Cancer; 2010 Sep; 55(3):401-6. PubMed ID: 20232448 [TBL] [Abstract][Full Text] [Related]
30. Immunization of newborns with bacterial conjugate vaccines. van den Biggelaar AH; Pomat WS Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221 [TBL] [Abstract][Full Text] [Related]
31. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience]. Konradsen HB; Henrichsen J Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383 [TBL] [Abstract][Full Text] [Related]
32. The place of pneumococcal vaccination. Drug Ther Bull; 1998 Oct; 36(10):73-6. PubMed ID: 10194871 [No Abstract] [Full Text] [Related]
33. The immunocompromised host: immune alterations in splenectomized patients and clinical implications. Jirillo E; Mastronardi ML; Altamura M; Munno I; Miniello S; Urgesi G; Amati L Curr Pharm Des; 2003; 9(24):1918-23. PubMed ID: 12871175 [TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of disease due to type b Haemophilus influenzae. Aubrey R; Tang C Methods Mol Med; 2003; 71():29-50. PubMed ID: 12374027 [No Abstract] [Full Text] [Related]
36. Protection against infections with Streptococcus pneumoniae and Haemophilus influenzae type B in a population of splenectomized individuals with varying vaccination status. Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB Adv Exp Med Biol; 1997; 418():833-5. PubMed ID: 9331782 [No Abstract] [Full Text] [Related]
37. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316 [TBL] [Abstract][Full Text] [Related]